1. Jin, Xin, Shi, Haida, Li, Zhi, Ma, Huanxian, Shi, Xianjie. 2022. Characterizing PTP4A3/PRL-3 as the Potential Prognostic Marker Gene for Liver Hepatocellular Carcinoma. In Journal of oncology, 2022, 2717056. doi:10.1155/2022/2717056. https://pubmed.ncbi.nlm.nih.gov/36213837/
2. Pu, Yunqiu, Sun, Fengxia, Sun, Rongli, Zhang, Juan, Pu, Yuepu. 2020. PTP4A3, A Novel Target Gene of HIF-1alpha, Participates in Benzene-Induced Cell Proliferation Inhibition and Apoptosis through PI3K/AKT Pathway. In International journal of environmental research and public health, 17, . doi:10.3390/ijerph17030910. https://pubmed.ncbi.nlm.nih.gov/32024182/
3. Song, Qian, Zheng, Yutian, Wu, Junzhou, Li, Zhongwu, Lian, Shenyi. 2021. PTP4A3 Is a Prognostic Biomarker Correlated With Immune Infiltrates in Papillary Renal Cell Carcinoma. In Frontiers in immunology, 12, 717688. doi:10.3389/fimmu.2021.717688. https://pubmed.ncbi.nlm.nih.gov/34630392/
4. McQueeney, Kelley E, Salamoun, Joseph M, Ahn, Jennifer G, Wipf, Peter, Lazo, John S. 2018. A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesion. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 32, 5661-5673. doi:10.1096/fj.201701446R. https://pubmed.ncbi.nlm.nih.gov/29746167/
5. Duciel, Laura, Anezo, Océane, Mandal, Kalpana, Manneville, Jean-Baptiste, Saule, Simon. 2019. Protein tyrosine phosphatase 4A3 (PTP4A3/PRL-3) promotes the aggressiveness of human uveal melanoma through dephosphorylation of CRMP2. In Scientific reports, 9, 2990. doi:10.1038/s41598-019-39643-y. https://pubmed.ncbi.nlm.nih.gov/30816227/
6. Grönroos, Toni, Teppo, Susanna, Mehtonen, Juha, Heinäniemi, Merja, Lohi, Olli. 2016. Overexpression of PTP4A3 in ETV6-RUNX1 acute lymphoblastic leukemia. In Leukemia research, 54, 1-6. doi:10.1016/j.leukres.2016.12.005. https://pubmed.ncbi.nlm.nih.gov/28063378/
7. Yeh, Hsin-Chih, Huang, Chun-Nung, Li, Ching-Chia, Li, Chien-Feng, Wu, Wen-Jeng. 2015. Overexpression of PTP4A3 is associated with metastasis and unfavorable prognosis in bladder cancer. In World journal of urology, 34, 835-46. doi:10.1007/s00345-015-1698-x. https://pubmed.ncbi.nlm.nih.gov/26433386/
8. Cramer, Julie M, Zimmerman, Mark W, Thompson, Tim, Lazo, John S, Lagasse, Eric. 2014. Deletion of Ptp4a3 reduces clonogenicity and tumor-initiation ability of colitis-associated cancer cells in mice. In Stem cell research, 13, 164-171. doi:10.1016/j.scr.2014.05.004. https://pubmed.ncbi.nlm.nih.gov/24950307/
9. den Hollander, Petra, Rawls, Kathryn, Tsimelzon, Anna, Mills, Gordon B, Brown, Powel H. 2016. Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival. In Cancer research, 76, 1942-53. doi:10.1158/0008-5472.CAN-14-0673. https://pubmed.ncbi.nlm.nih.gov/26921331/
10. Moyano Crespo, Gabriela Deisi, Cecenarro, Laura Anahí, Perez, Pablo, Torres, Alicia, Mukdsi, Jorge. 2020. Association of PTP4A3 expression and tumour size in functioning pituitary adenoma: a descriptive study. In Journal of clinical pathology, 74, 190-193. doi:10.1136/jclinpath-2020-206728. https://pubmed.ncbi.nlm.nih.gov/32616539/
智鼠故事 
